User menu

Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma.

Bibliographic reference Wilgenhof, S ; Corthals, Jonathan ; Heirman, C ; van Baren, Nicolas ; Lucas, Sophie ; et. al. Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma.. In: Journal of Clinical Oncology, Vol. 130, no. 8, p. 1960-1966 (2016)
Permanent URL http://hdl.handle.net/2078.1/172394